Effectiveness and safety of ultra-slow full power shockwave lithotripsy compared to mini–percutaneous nephrolithotomy and retrograde intrarenal surgery for treatment of lower calyceal stone between 1 and 2 cm with high attenuation value - Takeaways - MDSpire

Effectiveness and safety of ultra-slow full power shockwave lithotripsy compared to mini–percutaneous nephrolithotomy and retrograde intrarenal surgery for treatment of lower calyceal stone between 1 and 2 cm with high attenuation value

  • By

  • Mahmoud Abdallah

  • Mohammad Talaat Mohammad

  • Ahmed M. Ragheb

  • Akrm A. Elmarakbi

  • Ossama Mahmoud

  • November 11, 2025

  • 0 min

Share

  • 1

    Renal stones affect 10–15% of the global population, with calcium oxalate stones being the most common type.

  • 2

    For 1–2 cm lower calyceal stones, ultraslow SWL shows improved stone-free rates compared to mini-PNL and RIRS without compromising safety.

  • 3

    The study enrolled 360 patients with radio-opaque lower calyceal stones, comparing three treatment methods through a randomized design.

  • 4

    Treatment selection for renal stones depends on stone characteristics, renal anatomy, and patient comorbidities.

  • 5

    Ultraslow full-power SWL utilizes a novel dual-phase ramping protocol to enhance efficacy while minimizing renal injury risk.

Original Source(s)

Effectiveness and safety of ultra-slow full power shockwave lithotripsy compared to mini–percutaneous nephrolithotomy and retrograde intrarenal surgery for treatment of lower calyceal stone between 1 and 2 cm with high attenuation value

  • by Mahmoud Abdallah, Mohammad Talaat Mohammad, Ahmed M. Ragheb, Akrm A. Elmarakbi, Ossama Mahmoud

  • November 11, 2025

Related Content

Multivariable regression analysis of perioperative parameters for a novel pulsed solid-state Thulium: YAG laser with high peak power versus Holmium: YAG laser in prostate enucleation

Atlantic Health System and Atlantic Center for Research Deliver New Chapter in Bladder Cancer Care

Dr. Sandip Prasad leads an international trial that brings new bladder-sparing therapy to patients

  • by

  • July 23, 2025

  • 5 min
Management of clinical failure after minimally invasive surgical therapies (MIST) for BPH: repeat MIST versus resection, enucleation or ablation—a narrative review from EAU endourology